Literature DB >> 10546486

Molecular aspects of fluconazole resistance development in Candida albicans.

R Franz1, M Ruhnke, J Morschhäuser.   

Abstract

Serial Candida albicans isolates from recurrent episodes of oropharyngeal candidosis (OPC) in four AIDS patients which became fluconazole-resistant during therapy were analysed by molecular methods. The CARE-2 fingerprint patterns of the isolates demonstrated that in all four patients fluconazole resistance developed in a previously more susceptible strain. In two cases resistance correlated with enhanced expression of genes encoding multiple drug resistance proteins that mediate active drug efflux. Enhanced mRNA levels of the CDR1/CDR2 genes encoding ABC transporters were observed in fluconazole-resistant isolates from one patient compared with the corresponding susceptible isolates. The fluconazole-resistant isolates from another patient exhibited high mRNA levels of the MDR1 gene encoding a membrane transport protein of the major facilitator superfamily that was not detectably expressed in any of the fluconazole-susceptible isolates. These results demonstrate that in AIDS patients with recurrent OPC the development of fluconazole resistance is usually caused by molecular changes in a previously susceptible C. albicans strain from the same patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10546486     DOI: 10.1046/j.1439-0507.1999.00498.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  50 in total

1.  Proteomic analysis of azole resistance in Candida albicans clinical isolates.

Authors:  Massoumeh Z Hooshdaran; Katherine S Barker; George M Hilliard; Harald Kusch; Joachim Morschhäuser; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.

Authors:  Sanjiveeni Dhamgaye; Frederic Devaux; Raman Manoharlal; Patrick Vandeputte; Abdul Haseeb Shah; Ashutosh Singh; Corinne Blugeon; Dominique Sanglard; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

3.  A Cationic Polymer That Shows High Antifungal Activity against Diverse Human Pathogens.

Authors:  Leslie A Rank; Naomi M Walsh; Runhui Liu; Fang Yun Lim; Jin Woo Bok; Mingwei Huang; Nancy P Keller; Samuel H Gellman; Christina M Hull
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  Nylon-3 polymers active against drug-resistant Candida albicans biofilms.

Authors:  Runhui Liu; Xinyu Chen; Shaun P Falk; Kristyn S Masters; Bernard Weisblum; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2015-02-04       Impact factor: 15.419

Review 5.  The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.

Authors:  Joachim Morschhäuser
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

6.  Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate.

Authors:  Davina Hiller; Stephanie Stahl; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

7.  A genome-wide steroid response study of the major human fungal pathogen Candida albicans.

Authors:  Dibyendu Banerjee; Nuria Martin; Soumyadeep Nandi; Sudhanshu Shukla; Angel Dominguez; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Mycopathologia       Date:  2007-06-16       Impact factor: 2.574

8.  Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.

Authors:  Kasturi Mukhopadhyay; Tulika Prasad; Preeti Saini; Thomas J Pucadyil; Amitabha Chattopadhyay; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains.

Authors:  H Kusch; K Biswas; S Schwanfelder; S Engelmann; P D Rogers; M Hecker; J Morschhäuser
Journal:  Mol Genet Genomics       Date:  2004-04-28       Impact factor: 3.291

10.  Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.

Authors:  Indresh Kumar Maurya; Chaitanya Kumar Thota; Sachin Dev Verma; Jyotsna Sharma; Manpreet Kaur Rawal; Balaguru Ravikumar; Sobhan Sen; Neeraj Chauhan; Andrew M Lynn; Virander Singh Chauhan; Rajendra Prasad
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.